Document 3140 DOCN M94A3140 TI Natural history of HIV-infection in Bulgaria. DT 9412 AU Plochev KS; Dicov I; Duchovnicova T; Radinov A; Brankova J; Penkova K; Valcova I; Doganova I; M. M. A.-Centre of immunology, Sofia, Bulgaria. SO Int Conf AIDS. 1994 Aug 7-12;10(1):144 (abstract no. PB0003). Unique Identifier : AIDSLINE ICA10/94369435 AB OBJECTIVE: An analysis of the course of the HIV-infection in Bulgaria for the period 1986-93 was performed. METHODS: The patients were exposed to epidemiologecal, clinical, paraclinical and immunological analysis. The main methods used were flow cytometry, laser nephelometry, CAT, sonography, and standart clinical procedures. For statistical analysis was used a software product Microsoft Excel for Windows 5.0. RESULTS: For the period of investigation at least 4 mln bulgarians and 72000 foreigners were tested. 124 HIV+ bulgarians/0.003% of the tested population/and 90 foreigners were found. 24 infected bulgarians developed a clinic of AIDS and 20 of them died. Clinical investigations showed that 68% of HIV-infected suffered of oportunistic infections, distributed as follow: 36%-bacterial, 28%-fungal, 20%-viral, and 16%-parasitic infections. 6% developed neoplasias and 26% were asymptomatic. Mycobacterial and pneumocystis carinii infections were very rare. 84 HIV-infected were followed up by immunophenotyping. DISCUSSIONS AND CONCLUSIONS: 1. HIV-infections has spread with a low intensity in Bulgaria. 2. Epidemiological data showed that the infection is developed by African type. 3. It is viewed very high mortality on the base of late recognizing. 4. Clinical and immunological approach for control of the infection allow us to precisely define the clinical stage of the disease. DE Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/MORTALITY/ PHYSIOPATHOLOGY AIDS-Related Opportunistic Infections/EPIDEMIOLOGY/ PHYSIOPATHOLOGY Bulgaria/EPIDEMIOLOGY Comparative Study Human HIV Infections/COMPLICATIONS/*EPIDEMIOLOGY/*PHYSIOPATHOLOGY HIV Seropositivity/*EPIDEMIOLOGY/*PHYSIOPATHOLOGY Neoplasms/COMPLICATIONS Prevalence MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).